Related Experiment Video
Updated: Nov 8, 2025

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
Targeting microRNAs by curcumin: implication for cancer therapy
Fatemeh Sadoughi1, Parisa Maleki Dana1, Zatollah Asemi1
1Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.
Abstract:
In spite of all the investigations in the past 20 years that established a great body of knowledge in cancer therapy, utilizing some elderly methods such as plant compound administration might still be useful. Curcumin is a bioactive polyphenol, which has many anticancer properties but its capability in modulating miRNA expression has opened new doors in the field of cancer-targeted therapy. MiRNAs are a class of small noncoding RNAs that are able to regulate gene expression and signaling. In addition, some other effects of these RNAs such as modulating cell differentiation and regulation of cell cycle have made miRNAs great candidates for personalized cancer treatment. In this review, we try to find some answers to the questions on how curcumin exerts its impacts on cancer hallmarks through miRNAs and whether chemotherapy can be replaced by this beneficial plant compound.
Insights
Curcumin, a plant compound, impacts cancer by altering microRNA (miRNA) expression, offering potential for targeted cancer therapy. This review explores curcumin
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Despite advances in cancer therapy, natural compounds like curcumin show promise.
- Curcumin, a polyphenol, possesses anticancer properties.
- MicroRNAs (miRNAs) are key regulators of gene expression and cellular processes relevant to cancer.
Purpose of the Study:
- To review how curcumin influences cancer hallmarks via miRNA modulation.
- To assess curcumin's potential as an alternative or adjunct to chemotherapy.
Main Methods:
- Literature review of studies on curcumin, miRNAs, and cancer.
- Analysis of curcumin's molecular mechanisms targeting miRNA pathways.
- Evaluation of evidence for curcumin's efficacy in preclinical and clinical cancer models.
Main Results:
- Curcumin modulates the expression of specific miRNAs involved in cancer progression.
- These miRNA changes affect cancer hallmarks including proliferation, apoptosis, and metastasis.
- Curcumin's effects on miRNAs present a novel avenue for cancer treatment strategies.
Conclusions:
- Curcumin's ability to regulate miRNAs provides a mechanism for its anticancer effects.
- Curcumin holds potential as a targeted therapy, possibly complementing or replacing chemotherapy.
- Further research is warranted to fully elucidate curcumin-miRNA interactions for clinical application.
Related Concept Videos
MicroRNAs
MicroRNAs
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Destabilize Microtubules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

